VITRAKVI sol 20 mg/ml 2 fl 50 ml
7680672820026
CH-67282
L01EX12
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6728201
- CPT
- -
- Packaging group
- 100
- Unit
- ml
- Composition
- larotrectinibum 20 mg ut larotrectinibi sulfas, acidum citricum, maltodextrinum, triethylis citras, aromatica (Erdbeer) cum alcohol benzylicus, propylenglycolum, hydroxypropylbetadexum 174.6 mg, E 211 2 mg, natrii citras dihydricus, sucralosum, aqua purificata, ad solutionem pro 1 ml corresp. natrium max. 4.17 mg.
Articles (1)
Vitrakvi 20 mg/ml, Lösung zum Einnehmen
Lösung
100
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
larotrectinibum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
larotrectinibi sulfas
|
- | Substance | WIZUS |
|
acidum citricum
|
- | Substance | HNIDK |
|
maltodextrinum
|
- | Substance | HNIDK |
|
triethylis citras
|
- | Substance | HNIDK |
|
aromatica
|
- | Substance | AROMA |
|
alcohol benzylicus
|
- | Substance | HBESI |
|
propylenglycolum
|
- | Substance | HNIDK |
|
hydroxypropylbetadexum
|
174.6 MG | Substance | HBESI |
|
E 211
|
2.0 MG | Substance | HBESI |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
sucralosum
|
- | Substance | HNIDK |
|
aqua purificata
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 2118.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2022
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 67282
- Drug name
- Vitrakvi, Lösung zum Einnehmen
- Galenic form
- LSOR
- ATC Code
- L01EX12
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/05/2020
- Authorization expiration date
- 19/02/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VITRAKVI sol 20 mg/ml 2 fl 50 ml
- Description (DE)
- VITRAKVI Lös 20 mg/ml 2 Fl 50 ml
- Market launch
- 28/05/2020
- Narcotic (BTM)
- No